General Information of the Compound
| Compound ID |
CP0445631
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
[(19S)-10,19-diethyl-7-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-19-yl] 12-(hydroxyamino)-12-oxododecanoate
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C34H41N3O8
|
||||||||||||||||||
| Molecular Weight |
619.715
|
||||||||||||||||||
| Canonical SMILES |
CCc1c2Cn3c(cc4c(COC(=O)[C@@]4(CC)OC(=O)CCCCCCCCCCC(=O)NO)c3=O)-c2nc2ccc(O)cc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C34H41N3O8/c1-3-22-23-17-21(38)15-16-27(23)35-31-24(22)19-37-28(31)18-26-25(32(37)41)20-44-33(42)34(26,4-2)45-30(40)14-12-10-8-6-5-7-9-11-13-29(39)36-43/h15-18,38,43H,3-14,19-20H2,1-2H3,(H,36,39)/t34-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
SLAZSKUYTGFSHH-UMSFTDKQSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00991, Histone deacetylase 1
Protein ID: PT00995, Histone deacetylase 3
Protein ID: PT01213, Histone deacetylase 6